Manufacturers are working to meet the demand and the FDA is helping with anything we can do to increase supply
doi: 10.3389/fnut.2025.1702028 Received 09 September 2025 Revised 09 December 2025 Accepted 10 December 2025 Published 08 January 2026 Volume 12 - 2025 Edited by Lus Pedro Rato, University of vora, Portugal Reviewed by Jean-Marie Exbrayat, Catholic University of Lyon, France Ayad Palani, University of Garmian, Iraq Kosar Babaei, Neyshabur University of Medical Sciences, Iran Updates Copyright 2026 Zeevi, arac, Perovi, Zekovi and Stojsavljevi
Dont have the time to visit us
Drugmakers such as Eli Lilly and Co, Amgen Inc and Novo Nordisk are racing to grab a share of the obesity drugs market
The medications come in a well-insulated box
GLP-1 (glucagon-like peptide-1) is a hormone involved in appetite regulation and insulin secretion